5-(2,4-dichlorophenoxy)pentyl bromide | 37136-85-9

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 5-(2,4-dichlorophenoxy)pentyl bromide
• 英文别名: (5-bromo-pentyl)-(2,4-dichloro-phenyl)-ether；(5-Brom-pentyl)-(2,4-dichlor-phenyl)-aether；2.4-Dichlor-1-(5-brom-pentyloxy)-benzol；5-Brom-1-(2.4-dichlor-phenoxy)-pentan；5-(2.4-Dichlor-phenoxy)-pentylbromid；1-[(5-bromopentyl)oxy]-2,4-dichloro-benzene；1-[(5-Bromopentyl)oxy]-2,4-dichlorobenzene；1-(5-bromopentoxy)-2,4-dichlorobenzene
• CAS: 37136-85-9
• 化学式: C₁₁H₁₃BrCl₂O
• 分子量: 312.034
• InChiKey: OIQZHZGAZWQZDU-UHFFFAOYSA-N

物化性质

• 熔点：
  39-40 °C
• 沸点：
  135-150 °C(Press: 0.15 Torr)
• 密度：
  1.440±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  5.5
• 重原子数：
  15
• 可旋转键数：
  6
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.45
• 拓扑面积：
  9.2
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  5-(2,4-dichlorophenoxy)pentyl bromide 在 potassium dihydrogenphosphate 、 sodium methylate 作用下， 以 乙醚 、 N,N-二甲基甲酰胺 为溶剂， 反应 38.17h， 生成 Methyl 3-cyano-4-[5-(2,4-dichlorophenoxy)pentylsulfanyl]-3-hydroxybutanoate
  参考文献：
  名称：

  ATP-Citrate Lyase as a Target for Hypolipidemic Intervention. Design and Synthesis of 2-Substituted Butanedioic Acids as Novel, Potent Inhibitors of the Enzyme

  摘要：

  ATP-citrate lyase is the primary enzyme responsible for the synthesis of cytosolic acetyl-CoA in many tissues. Inhibitors of the enzyme represent a potentially novel class of hypolipidemic agent, which are anticipated to have combined hypocholesterolemic and hypotriglyceridemic properties. A series of a-substituted butanedioic acids have been designed and synthesized as inhibitors of the enzyme, The best compounds, 58, 68, 71, 74 have reversible K-i's in the 1-3 mu M range against the isolated rat enzyme, As representative of this compound class, 58, has been shown to exert its inhibitory action through a mainly competitive mechanism with respect to citrate and a noncompetitive one with respect to CoA. None of the inhibitors were able to inhibit cholesterol and/or fatty acid synthesis in HepG2 cells. This has been attributed to the adverse physicochemical properties of the molecules leading to a lack of cell penetration. Despite this, a lead structural class of compound has been identified with the potential for modification into potent, cell-penetrant, and efficacious inhibitors of ATP-citrate lyase.

  DOI：

  10.1021/jm960167w
• 作为产物：
  描述：

  1,5-二溴戊烷 、 2,4-二氯酚 在 氢氧化钾 作用下， 生成 5-(2,4-dichlorophenoxy)pentyl bromide
  参考文献：
  名称：

  植物生长物质：ω-芳基-和ω-芳氧基-烷基羧酸

  摘要：

  结合植物生长活性的研究，合成了许多 R[CH2]CO2H 型羧酸。它们包括 ω-取代的烷基羧酸的五个同源系列的前六或七个成员，即邻甲氧基苯氧基-、对氯苯氧基-、2:4-二氯苯氧基-、2:4:5-三氯苯氧基-和 1-萘基-烷基羧酸；和五个1-萘基-烷基羧酸，其中烷基链被支化或以其他方式改性。苯氧酸是通过经典方法制备的，但对于许多 1-萘酸，采用了涉及使用有机镉化合物的方法。

  DOI：

  10.1002/jsfa.2740070504

文献信息

• BE626725
  申请人：——

  公开号：——

  公开（公告）日：——
• Design, synthesis, antibacterial and QSAR studies of benzimidazole and imidazole chloroaryloxyalkyl derivatives
  作者：A. Khalafi-Nezhad、M.N. Soltani Rad、H. Mohabatkar、Z. Asrari、B. Hemmateenejad

  DOI：10.1016/j.bmc.2005.01.014

  日期：2005.3

  In view of obtaining some potential antibacterial compounds, we have described synthesis of some chloroaryloxyalkyl imidazole and benzimidazole derivatives. The relevant step in the synthetic sequence was the initial condensation of 4-chloro or 2,4-dichlorophenol with 1, n-dibromoalkanes (n = 2, 4, 5) to provide compounds 3a-f in sufficient yields. The subsequent condensation of 3a-f with some imidazole derivatives and benzimidazole afforded products 4a-1 and 5a-e in good yields. Some of compounds 4a-1 as well as 5a-e were tested in vitro against Salmonella typhi O-901 and Staphylococcus aureus A 15091. Compounds 4a and 4c showed considerable bactericidal activities against tested bacteria. Compound 4b showed significant activity against S. aureus A 15091 but was inactive against S. typhi O-901. Other compounds showed intermediate activities against S. aureus A 15091 but most of them were inactive against S. typhi O-901. Serniempirical AM1 calculations showed that negative electrostatic potentials around oxygen of the phenoxy and nitrogen of the imidazole moieties have direct effect on the antibacterial activity towards S. aureus A 15091. In QSAR analysis, different electronic, topologic, functional groups and physicochemical descriptors were calculated for each molecule and a three parametric equation was found between the log MIC and HOMO energy, hydration energy and number of primary carbon atoms of the molecules. (c) 2005 Elsevier Ltd. All rights reserved.
• Ejmocki,Z.; Eckstein,Z., Roczniki Chemii, 1971, vol. 45, p. 345 - 353
  作者：Ejmocki,Z.、Eckstein,Z.

  DOI：——

  日期：——
• Synerholm; Zimmerman, Contributions from Boyce Thompson Institute, 1947, vol. 14, p. 369,372
  作者：Synerholm、Zimmerman

  DOI：——

  日期：——
• ATP-Citrate Lyase as a Target for Hypolipidemic Intervention. Design and Synthesis of 2-Substituted Butanedioic Acids as Novel, Potent Inhibitors of the Enzyme
  作者：Andrew D. Gribble、Roland E. Dolle、Antony Shaw、David McNair、Riccardo Novelli、Christine E. Novelli、Brian P. Slingsby、Virendra P. Shah、David Tew、Barbara A. Saxty、Mark Allen、Pieter H. Groot、Nigel Pearce、John Yates

  DOI：10.1021/jm960167w

  日期：1996.1.1

  ATP-citrate lyase is the primary enzyme responsible for the synthesis of cytosolic acetyl-CoA in many tissues. Inhibitors of the enzyme represent a potentially novel class of hypolipidemic agent, which are anticipated to have combined hypocholesterolemic and hypotriglyceridemic properties. A series of a-substituted butanedioic acids have been designed and synthesized as inhibitors of the enzyme, The best compounds, 58, 68, 71, 74 have reversible K-i's in the 1-3 mu M range against the isolated rat enzyme, As representative of this compound class, 58, has been shown to exert its inhibitory action through a mainly competitive mechanism with respect to citrate and a noncompetitive one with respect to CoA. None of the inhibitors were able to inhibit cholesterol and/or fatty acid synthesis in HepG2 cells. This has been attributed to the adverse physicochemical properties of the molecules leading to a lack of cell penetration. Despite this, a lead structural class of compound has been identified with the potential for modification into potent, cell-penetrant, and efficacious inhibitors of ATP-citrate lyase.